US Stock MarketDetailed Quotes

Aclaris Therapeutics (ACRS)

Watchlist
  • 4.600
  • +0.070+1.55%
Trading Jan 23 10:21 ET
498.39MMarket Cap-2.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics (ACRS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
5.03%31.25M
126.62%17.57M
Operating revenue
-24.09%3.3M
-35.76%1.78M
-39.32%1.46M
-40.09%18.72M
-47.58%9.21M
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
5.95%31.25M
131.55%17.57M
Cost of revenue
1.70%2.45M
-3.09%1.85M
-17.61%1.52M
-14.51%15.46M
44.70%9.3M
-70.61%2.41M
19.91%1.91M
-1.55%1.84M
51.18%18.08M
324.57%6.43M
Gross profit
-56.14%850K
-108.52%-73K
-110.93%-61K
-75.23%3.26M
-100.81%-90K
77.80%1.94M
209.39%857K
-15.33%558K
-25.99%13.17M
78.59%11.14M
Operating expense
54.18%17.9M
24.60%16.84M
6.20%17.72M
-56.91%55.79M
-59.90%13.98M
-62.15%11.61M
-58.52%13.51M
-46.81%16.69M
25.78%129.48M
23.54%34.86M
Selling and administrative expenses
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
23.73%31.1M
14.95%8.21M
-General and administrative expense
-13.83%4.87M
13.34%5.39M
-10.30%6.14M
-28.60%22.2M
-39.69%4.95M
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
23.73%31.1M
14.95%8.21M
Research and development costs
118.74%13.03M
30.71%11.45M
17.66%11.58M
-65.86%33.59M
-66.13%9.03M
-75.05%5.96M
-65.35%8.76M
-56.41%9.85M
26.44%98.38M
26.45%26.65M
Operating profit
-76.29%-17.05M
-33.62%-16.91M
-10.25%-17.78M
54.84%-52.53M
40.68%-14.07M
67.31%-9.67M
60.82%-12.65M
47.49%-16.13M
-36.59%-116.31M
-7.91%-23.72M
Net non-operating interest income expense
-8.64%1.82M
8.03%2.02M
8.84%2.17M
-14.03%1.99M
1.87M
1.99M
Non-operating interest income
-8.64%1.82M
8.03%2.02M
8.84%2.17M
----
----
-14.03%1.99M
--1.87M
--1.99M
----
----
Other net income (expense)
555.32%616K
-169.50%-539K
119.04%533K
-389.59%-79.54M
-371.94%-76.63M
104.72%94K
-107.34%-200K
-209.46%-2.8M
1,665.91%27.47M
598.23%28.18M
Special income (charges)
87.50%-100K
-650.00%-1.5M
89.29%-300K
-571.62%-89.41M
-535.18%-85.61M
59.86%-800K
-141.75%-200K
-450.00%-2.8M
503.34%18.96M
377.06%19.67M
-Less：Restructuring and merger&acquisition
-87.50%100K
650.00%1.5M
-89.29%300K
541.05%89.41M
535.18%85.61M
-52.94%800K
113.33%200K
450.00%2.8M
-531.30%-20.27M
-377.06%-19.67M
-Write off
----
----
----
--0
--0
--0
--0
----
--1.31M
--0
Other non- operating income (expenses)
-19.91%716K
-48.55%961K
-58.14%833K
15.96%9.87M
--8.97M
--894K
-16.83%1.87M
13.20%1.99M
188.83%8.51M
----
Income before tax
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-48.64%-132.07M
-5,096.56%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-2.23%-88.85M
93.28%-1.86M
Income tax
0
-367K
Net income
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
Net income continuous Operations
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
Minority interest income
Net income attributable to the parent company
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-92.64%-14.61M
-40.44%-15.43M
10.96%-15.09M
-49.26%-132.07M
-6,375.65%-96.55M
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
Basic earnings per share
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
42.86%-0.24
4.51%-1.27
95.12%-0.02
Diluted earnings per share
-9.09%-0.12
13.33%-0.13
50.00%-0.12
-34.65%-1.71
-4,950.00%-1.01
73.17%-0.11
64.29%-0.15
42.86%-0.24
4.51%-1.27
95.12%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M-5.14%2.4M5.03%31.25M126.62%17.57M
Operating revenue -24.09%3.3M-35.76%1.78M-39.32%1.46M-40.09%18.72M-47.58%9.21M-53.18%4.35M47.99%2.77M-5.14%2.4M5.95%31.25M131.55%17.57M
Cost of revenue 1.70%2.45M-3.09%1.85M-17.61%1.52M-14.51%15.46M44.70%9.3M-70.61%2.41M19.91%1.91M-1.55%1.84M51.18%18.08M324.57%6.43M
Gross profit -56.14%850K-108.52%-73K-110.93%-61K-75.23%3.26M-100.81%-90K77.80%1.94M209.39%857K-15.33%558K-25.99%13.17M78.59%11.14M
Operating expense 54.18%17.9M24.60%16.84M6.20%17.72M-56.91%55.79M-59.90%13.98M-62.15%11.61M-58.52%13.51M-46.81%16.69M25.78%129.48M23.54%34.86M
Selling and administrative expenses -13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M-22.14%6.84M23.73%31.1M14.95%8.21M
-General and administrative expense -13.83%4.87M13.34%5.39M-10.30%6.14M-28.60%22.2M-39.69%4.95M-16.84%5.65M-34.87%4.75M-22.14%6.84M23.73%31.1M14.95%8.21M
Research and development costs 118.74%13.03M30.71%11.45M17.66%11.58M-65.86%33.59M-66.13%9.03M-75.05%5.96M-65.35%8.76M-56.41%9.85M26.44%98.38M26.45%26.65M
Operating profit -76.29%-17.05M-33.62%-16.91M-10.25%-17.78M54.84%-52.53M40.68%-14.07M67.31%-9.67M60.82%-12.65M47.49%-16.13M-36.59%-116.31M-7.91%-23.72M
Net non-operating interest income expense -8.64%1.82M8.03%2.02M8.84%2.17M-14.03%1.99M1.87M1.99M
Non-operating interest income -8.64%1.82M8.03%2.02M8.84%2.17M---------14.03%1.99M--1.87M--1.99M--------
Other net income (expense) 555.32%616K-169.50%-539K119.04%533K-389.59%-79.54M-371.94%-76.63M104.72%94K-107.34%-200K-209.46%-2.8M1,665.91%27.47M598.23%28.18M
Special income (charges) 87.50%-100K-650.00%-1.5M89.29%-300K-571.62%-89.41M-535.18%-85.61M59.86%-800K-141.75%-200K-450.00%-2.8M503.34%18.96M377.06%19.67M
-Less：Restructuring and merger&acquisition -87.50%100K650.00%1.5M-89.29%300K541.05%89.41M535.18%85.61M-52.94%800K113.33%200K450.00%2.8M-531.30%-20.27M-377.06%-19.67M
-Write off --------------0--0--0--0------1.31M--0
Other non- operating income (expenses) -19.91%716K-48.55%961K-58.14%833K15.96%9.87M--8.97M--894K-16.83%1.87M13.20%1.99M188.83%8.51M----
Income before tax -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-48.64%-132.07M-5,096.56%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-2.23%-88.85M93.28%-1.86M
Income tax 0-367K
Net income -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M
Net income continuous Operations -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M
Minority interest income
Net income attributable to the parent company -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -92.64%-14.61M-40.44%-15.43M10.96%-15.09M-49.26%-132.07M-6,375.65%-96.55M74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M
Basic earnings per share -9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.1542.86%-0.244.51%-1.2795.12%-0.02
Diluted earnings per share -9.09%-0.1213.33%-0.1350.00%-0.12-34.65%-1.71-4,950.00%-1.0173.17%-0.1164.29%-0.1542.86%-0.244.51%-1.2795.12%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +2.47%
Sample Name
Sample Code
 +2.08%
Sample Name
Sample Code
 +1.90%
4
Clean Energy Fuels
CLNE
+1.82%
5
NVIDIA
NVDA
+1.37%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +18.76%
Sample Name
Sample Code
 +8.37%
Sample Name
Sample Code
 +4.16%
4
H World Group
HTHT
+4.04%
5
Pony AI
PONY
+4.00%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -